HOME › Research Insight › Market Leaders - Antifreeze Proteins Market

The antifreeze proteins market is projected to grow at a CAGR of 30.0%, to reach a value of USD 10.0 million by 2023 from USD 2.7 million in 2018. The key players profiled in the report have a strong presence in the global antifreeze protein market; these include Kaneka Corp (Japan), Aqua Bounty Technologies (US), Unilever (Netherlands), AF Protein (US), Sirona Biochem (Canada), and ProtoKinetix (US).

These players adopted growth strategies such as agreements and collaborations to cater to the increasing demand for antifreeze proteins. Companies have been expanding their operations through agreements and collaborations in various regions across the globe to establish themselves as leading players in the antifreeze proteins market.

Unilever focuses on product innovation and collaborations to strengthen their presence in the market. The company operates through three business segments, namely, home care, personal care, and food & refreshments. Unilever sells antifreeze protein products under the name of ice structuring proteins. The company has entered into a research collaboration with the US Environmental Protection Agency (EPA) to develop products. The company has advanced manufacturing facilities and focus on strengthening its market position by expanding their capacities.

To know about the assumptions considered for the study download the pdf brochure

Aqua Bounty Technologies (US) conducts R&D of the commercial viability of a group of proteins commonly known as antifreeze proteins. The company focuses on providing antifreeze proteins for sale to the medical, cosmetics, and research & development community. The company provides antifreeze protein Types I and III as well as antifreeze glycoproteins under the brand name of LiftLab. The company’s products are used for the control of cold-induced damage in medical, food, and cosmetic products.

ProtoKinetix (US) has entered into a Material Transfer Agreement (MTA) with International Biotech Company (US) to test the effects AAGP have on the cryopreservation of primary mammalian tissue cells, enhancing the viability of primary mammalian cells, and cell lines under stressed culture conditions. The company entered into a joint venture with Proactive Immune Sciences (US) to conduct research to test the effect of patented anti-aging glycopeptide AAGP on the immune cell cryopreservation protocols used by Proactive Immune Sciences. ProtoKinetix operates in collaboration with Proactive Immune Sciences Corporation (US) to test AAGPs in immune cell cryopreservation recovery and a research agreement with the University of British Columbia to test neuronal retinal cells in living tissues for the treatment of macular degeneration.

Related Reports:

Antifreeze Proteins Market by Source (Fish, Plants, and Insects), End Use (Medical, Cosmetics, and Food), Type (Type I, Type III, and Antifreeze Glycoproteins), Form (Liquid and Solid), and Region - Global Forecast to 2023

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com